TFFP Overview

TFF Pharmaceuticals Delisting Announcement: TFF Pharmaceuticals, Inc. has notified Nasdaq of its intent to voluntarily delist its common stock in connection with the company's planned liquidation and dissolution, with the delisting expected to take effect around February 26, 2025.

Forward-Looking Statements Disclaimer: The company issued a disclaimer regarding forward-looking statements, highlighting potential risks and uncertainties that could affect the actual outcomes related to their wind-down operations.

Company Delisting Announcement: TFF Pharmaceuticals, Inc. has notified Nasdaq of its intent to voluntarily delist its common stock in connection with the planned liquidation and dissolution of the company, with the delisting expected to take effect around February 26, 2025.

Forward-Looking Statements Disclaimer: The announcement includes forward-looking statements that are subject to risks and uncertainties, indicating that actual results may differ from those projected, particularly regarding the wind-down process and market conditions.

Market Performance: U.S. stocks mostly declined, with the Nasdaq Composite dropping over 50 points and initial jobless claims rising to 242,000, exceeding market expectations.

Sector Movements: Real estate shares increased by 0.7%, while energy shares fell by 0.7%. Notable stock movements included Palisade Bio surging 73% and Sacks Parente Golf plummeting 80%.

DBV Technologies Stock Surge: DBV Technologies S.A. shares rose 36.9% in pre-market trading after announcing alignment with the FDA for an accelerated approval pathway for the Viaskin peanut patch in toddlers aged one to three years.

Market Movements: Various stocks experienced significant changes in pre-market trading, with Palisade Bio, Inc. gaining 125%, while Avinger, Inc. saw a decline of 50%.

U.S. Stock Market Performance: U.S. stocks saw gains with the Nasdaq Composite rising over 300 points, while Macy's reported better-than-expected third-quarter sales and adjusted EPS, projecting higher sales for 2024 despite a decline in adjusted EPS from the previous year.

Market Trends and Economic Indicators: Communication services shares increased by 3.1%, while health care shares fell by 1%. The Consumer Price Index rose 2.7% year-over-year in November 2024, indicating a slight acceleration in inflation, alongside a decline in U.S. crude inventories.

U.S. Stock Market Performance: U.S. stocks mostly rose, with the Nasdaq gaining over 1%, while the Consumer Price Index increased by 2.7% year-over-year in November 2024, indicating a trend of rising inflation.

Sector Movements and Commodities: Communication services shares saw a significant rise of 2.4%, while health care shares fell by 1.1%. In commodities, oil and gold prices increased, while European and Asian markets also showed mixed results.